Myalgia in liver transplant recipients after receiving tixagevimab/cilgavimab for pre‐exposure prophylaxis of COVID‐19: A case series-Reference-Cited by-同舟云学术

Myalgia in liver transplant recipients after receiving tixagevimab/cilgavimab for pre‐exposure prophylaxis of COVID‐19: A case series

Published:2022-08-23 Issue:6 Volume:24 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transplant Infectious Dis

Author:

Kleiboeker Hanna L.¹^ORCID,Jorgenson Margaret R.¹^ORCID,Smith Jeannina A.²^ORCID

Affiliation:

1. Department of Pharmacy University of Wisconsin Hospital and Clinics Madison Wisconsin USA

2. Department of Medicine Division of Infectious Diseases University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13932

Reference14 articles.

1. Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study

2. Outcomes of COVID‐19 in solid organ transplant recipients: A matched cohort study

3. FDA.Fact sheet for healthcare providers: emergency use authorization for Evushel (tixagevimab co‐packaged with cilgavimab). Accessed April 26 2022.https://www.fda.gov/media/154701/download

4. Immunogenicity of SARS‐CoV‐2 mRNA vaccine in solid organ transplant recipients

5. Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal antibodies as COVID-19 prophylaxis therapy in immunocompromised patient populations;International Journal of Infectious Diseases;2023-09

2. COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations;World Journal of Hepatology;2023-04-27

3. Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience;Viruses;2022-12-30

4. Efficacy and Safety of Tixagevimab/Cilgavimab to Prevent COVID-19 (Pre-Exposure Prophylaxis): A Systematic Review and Meta-Analysis;Diseases;2022-12-01

5. A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment;Viruses;2022-09-09